Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Clinical trial NCT00114101 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00114101
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

DS Stage I Multiple Myeloma DS Stage II Multiple Myeloma DS Stage III Multiple Myeloma Refractory Multiple Myeloma Smoldering Multiple Myeloma

Start date: 2004-12-15
Primary completion: 2012-12-31
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.